Adam Joseph Rosenberg - May 18, 2023 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
Director
Signature
/s/ Brian Woodard, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
May 18, 2023
Transactions value $
$0
Form type
4
Date filed
5/22/2023, 05:05 PM
Previous filing
Jun 1, 2022
Next filing
Jun 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELYM Common Stock 178K May 18, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right To Buy) Award $0 +10K $0.00 10K May 18, 2023 Common Stock 10K $3.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of May 18, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.